跳到正文

AACR 2026 年会

2026 年 4 月 17–22 日 · San Diego · 共 2429 条

超过 22,000 名参会者,7,400 余份摘要,其中创纪录的 265 篇临床试验摘要。本板块收录十五个信号方向的现场解读,以及晚破、临床试验与新药首发三类摘要。

4月18日周六
  1. AACR 官方会议报道60

    A Naturally Occurring Transfer System With Therapeutic Potential

    Educational Session on extracellular vesicles and particles (EVPs), with Crislyn D'Souza-Schorey (Notre Dame), Dolores Di Vizio (Cedars-Sinai) and David Lyden (Weill Cornell). Topics: the role of EVPs in the tumour microenvironment, large oncosomes as metastasis drivers and biomarkers, and T cell-derived EVPs boosting immunotherapy response in mice.

    还没有互动
  2. Elizabeth McKenna60

    Read more in

    暂无中文译文,显示英文原文。

    热度 33 赞0 回复0 转发
  3. AACR 官方会议报道60

    Meet and Greet for Global Scholar-in-Training Awardees

    Twenty Global Scholar-in-Training Award recipients are attending, including recipients of the new Amgen award for early-career researchers in Africa. Recipients presented their research and practiced elevator pitches.

    还没有互动
CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org